Is Green Tea worth prioritizing?
Green tea's longevity evidence rests mainly on large Asian cohort studies, with several meta-analyses and one small negative trial adding important context. Weighing that against the numbers, Green Tea is not a priority based on current data — the evidence is only moderate (55/100), and its estimated impact (42/100) is on the lower end too.
Sponsored By
Sponsors have no influence on evidence, impact scores, or the science itself.
🍵
Green Tea
Moderate evidence
Evidence
55
Impact
42